{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:39:24Z","timestamp":1792024764688,"version":"4.4.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Diabetes and its Complications"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.jdiacomp.2021.108106","type":"journal-article","created":{"date-parts":[[2021,12,31]],"date-time":"2021-12-31T10:48:45Z","timestamp":1640947725000},"page":"108106","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":81,"title":["Randomized comparison of self-monitored blood glucose (BGM) versus continuous glucose monitoring (CGM) data to optimize glucose control in type 2 diabetes"],"prefix":"10.1016","volume":"36","author":[{"given":"Richard M.","family":"Bergenstal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah M.","family":"Mullen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellie","family":"Strock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary L.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min X.","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdiacomp.2021.108106_bb0005","series-title":"Secondary CDC type 2 diabetes May 30, 2019","article-title":"CDC type 2 diabetes","author":"CDC","year":"2021"},{"key":"10.1016\/j.jdiacomp.2021.108106_bb0010","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1001\/archinte.164.13.1422","article-title":"The independent effect of type 2 diabetes mellitus on ischemic heart disease, stroke, and death: a population-based study of 13 000 men and women with 20 years of follow-up","volume":"164","author":"Almdal","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jdiacomp.2021.108106_bb0015","doi-asserted-by":"crossref","DOI":"10.2337\/db19-1280-P","article-title":"1280-P: effect of professional CGM (pCGM) on glucose management in type 2 diabetes patients in primary care","author":"Martens","year":"2019","journal-title":"Am Diabetes Assoc"},{"key":"10.1016\/j.jdiacomp.2021.108106_bb0020","first-page":"S-4","article-title":"Clinical use of continuous glucose monitoring in adults with type 2 diabetes.","volume":"19","author":"Carlson","year":"2017"},{"key":"10.1016\/j.jdiacomp.2021.108106_bb0025","doi-asserted-by":"crossref","first-page":"S2-17","DOI":"10.1089\/dia.2019.0034","article-title":"Utilizing the ambulatory glucose profile to standardize and implement continuous glucose monitoring in clinical practice","volume":"21","author":"Johnson","year":"2019","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.jdiacomp.2021.108106_bb0030","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1177\/1932296816628547","article-title":"The cost-effectiveness of real-time continuous glucose monitoring (RT-CGM) in type 2 diabetes","volume":"10","author":"Fonda","year":"2016","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/j.jdiacomp.2021.108106_bb0035","first-page":"S-16","article-title":"Metrics beyond hemoglobin A1c in diabetes management: time in range, hypoglycemia, and other parameters","volume":"19","author":"Wright","year":"2017"},{"key":"10.1016\/j.jdiacomp.2021.108106_bb0040","doi-asserted-by":"crossref","first-page":"95","DOI":"10.7326\/M16-2596","article-title":"Racial differences in the relationship of glucose concentrations and hemoglobin A1c levels","volume":"167","author":"Bergenstal","year":"2017","journal-title":"Ann Intern Med"},{"issue":"Supplement 1","key":"10.1016\/j.jdiacomp.2021.108106_bb0045","article-title":"Hemoglobin A1c (A1c) genetics contributes to A1c\/glucose mismatches in the multiethnic VA Million Veteran Program (MVP)","volume":"67","author":"Leong","year":"2018","journal-title":"Am Diabetes Assoc"},{"key":"10.1016\/j.jdiacomp.2021.108106_bb0050","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.2337\/dc21-S007","article-title":"7. Diabetes Technology: <em>Standards of Medical Care in Diabetes\u20142021<\/em>","volume":"44","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2021.108106_bb0055","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/S0140-6736(19)30368-X","article-title":"Automated insulin dosing guidance to optimise insulin management in patients with type 2 diabetes: a multicentre, randomised controlled trial","volume":"393","author":"Bergenstal","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jdiacomp.2021.108106_bb0060","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1089\/dia.2018.0298","article-title":"Implementation of basal\u2013bolus therapy in type 2 diabetes: a randomized controlled trial comparing bolus insulin delivery using an insulin patch with an insulin pen","volume":"21","author":"Bergenstal","year":"2019","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.jdiacomp.2021.108106_bb0065","doi-asserted-by":"crossref","first-page":"262","DOI":"10.2337\/dc10-1732","article-title":"Structured self-monitoring of blood glucose significantly reduces A1C levels in poorly controlled, noninsulin-treated type 2 diabetes: results from the Structured Testing Program study","volume":"34","author":"Polonsky","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2021.108106_bb0070","doi-asserted-by":"crossref","first-page":"32","DOI":"10.2337\/dc11-1438","article-title":"Short-and long-term effects of real-time continuous glucose monitoring in patients with type 2 diabetes","volume":"35","author":"Vigersky","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2021.108106_bb0075","series-title":"Multiple daily injections and continuous glucose monitoring in diabetes (DIaMonD)","author":"Price","year":"2014"},{"key":"10.1016\/j.jdiacomp.2021.108106_bb0080","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1177\/0145721709347601","article-title":"Effective use of paired testing in type 2 diabetes","volume":"35","author":"Parkin","year":"2009","journal-title":"Diabetes Educ"},{"key":"10.1016\/j.jdiacomp.2021.108106_bb0085","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2337\/diacare.10.1.111","article-title":"Ambulatory glucose profile: representation of verified self-monitored blood glucose data","volume":"10","author":"Mazze","year":"1987","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2021.108106_bb0090","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1089\/dia.2007.0293","article-title":"Characterizing glucose exposure for individuals with normal glucose tolerance using continuous glucose monitoring and ambulatory glucose profile analysis","volume":"10","author":"Mazze","year":"2008","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.jdiacomp.2021.108106_bb0095","first-page":"562","article-title":"Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the ambulatory glucose profile","volume":"7","author":"Bergenstal","year":"2013"},{"key":"10.1016\/j.jdiacomp.2021.108106_bb0100","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1016\/S0140-6736(16)31535-5","article-title":"Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial","volume":"388","author":"Bolinder","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jdiacomp.2021.108106_bb0105","series-title":"The role of blood glucose monitoring in diabetes management","author":"Weinstock","year":"2020"},{"key":"10.1016\/j.jdiacomp.2021.108106_bb0110","author":"IDC"},{"key":"10.1016\/j.jdiacomp.2021.108106_bb0115","series-title":"American Diabetes Association Scientific Meeting","article-title":"Reduced staff time with optimized work flows and standardized ambulatory glucose profile (AGP)","author":"Mullen","year":"2015"},{"key":"10.1016\/j.jdiacomp.2021.108106_bb0120","series-title":"Effect of professional CGM (pCGM) on glucose management in type 2 diabetes patients in primary care","author":"Simonson","year":"2021"},{"key":"10.1016\/j.jdiacomp.2021.108106_bb0125","doi-asserted-by":"crossref","first-page":"324","DOI":"10.2337\/ds19-0039","article-title":"Barriers to continuous glucose monitoring in people with type 1 diabetes: clinician perspectives","volume":"33","author":"Lanning","year":"2020","journal-title":"Diabetes Spectrum"},{"key":"10.1016\/j.jdiacomp.2021.108106_bb0130","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.2337\/dc21-S006","article-title":"6. Glycemic targets: standards of medical care in diabetes\u20142021","volume":"44","author":"ADA","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2021.108106_bb0135","series-title":"The relationships between time in range, hyperglycemia metrics, and HbA1c","author":"Beck","year":"2019"},{"key":"10.1016\/j.jdiacomp.2021.108106_bb0140","doi-asserted-by":"crossref","first-page":"400","DOI":"10.2337\/dc18-1444","article-title":"Validation of time in range as an outcome measure for diabetes clinical trials","volume":"42","author":"Beck","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2021.108106_bb0145","doi-asserted-by":"crossref","first-page":"994","DOI":"10.2337\/dc17-0636","article-title":"The fallacy of average: how using HbA1c alone to assess glycemic control can be misleading","volume":"40","author":"Beck","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2021.108106_bb0150","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.2337\/dc17-1600","article-title":"International consensus on use of continuous glucose monitoring","volume":"40","author":"Danne","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2021.108106_bb0155","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.2337\/dci17-0043","article-title":"Improving the clinical value and utility of CGM systems: issues and recommendations: a joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group","volume":"40","author":"Petrie","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2021.108106_bb0160","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.2337\/dci17-0049","article-title":"Maturation of CGM and glycemic measurements beyond HbA1c\u2014a turning point in research and clinical decisions","volume":"40","author":"Riddle","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2021.108106_bb0165","series-title":"American Diabetes Association Scientific Meeting","article-title":"Reaching an international consensus on standardizing continuous glucose monitoring (CGM) outcomes\u2014aligning clinicians, researchers, patients, and regulators","author":"Buckingham","year":"2017"},{"key":"10.1016\/j.jdiacomp.2021.108106_bb0170","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.2337\/dci19-0028","article-title":"Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range","volume":"42","author":"Battelino","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2021.108106_bb0175","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.2337\/dc19-1459","article-title":"Effects of continuous glucose monitoring on metrics of glycemic control in diabetes: a systematic review with meta-analysis of randomized controlled trials","volume":"43","author":"Maiorino","year":"2020","journal-title":"Diabetes Care"}],"container-title":["Journal of Diabetes and its Complications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872721003305?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872721003305?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:14:35Z","timestamp":1761005675000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056872721003305"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S1056872721003305"],"URL":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2021.108106","relation":{},"ISSN":["1056-8727"],"issn-type":[{"value":"1056-8727","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Randomized comparison of self-monitored blood glucose (BGM) versus continuous glucose monitoring (CGM) data to optimize glucose control in type 2 diabetes","name":"articletitle","label":"Article Title"},{"value":"Journal of Diabetes and its Complications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2021.108106","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108106"}}